- Home
- Hervycta Plus 150 Injection
Hervycta Plus 150 Injection Substitute
Hervycta Plus 150 Injection Substitute
All Substitutes & Brand Comparisons
RX
Trumab 150 Injection 7.2 ml
Glenmark Pharmaceuticals Ltd
₹6796.5
(₹774.04 per ml)
95% CHEAPERRX
Ontramab 150 mg Injection 7.2 ml
Celon Laboratories Pvt Ltd
₹10800
(₹1230.0 per ml)
93% CHEAPERRX
Priunta 150 mg Injection 7.2 ml
Abbott India Ltd
₹17990
(₹2198.78 per ml)
87% CHEAPERRX
Hermab 150 mg Injection 7.2 ml
RPG Life Sciences Ltd
₹19500
(₹2220.83 per ml)
87% CHEAPERRX
Hersima 150 mg Injection 7.2 ml
Alkem Laboratories Ltd
₹21093.5
(₹2402.32 per ml)
86% CHEAPERRX
Hervycta 150 Injection 1's
Dr Reddy's Laboratories Ltd
₹6093.5
(₹4996.7 per unit)
72% CHEAPERRX
Eleftha 150 mg Injection 1's
Intas Pharmaceuticals Ltd
₹6491.5
(₹5323.0 per unit)
70% CHEAPERRX
Neumab 150 Injection 1's
Del Trade International Pvt Ltd
₹5618
(₹5618.0 per unit)
69% CHEAPERRX
Kintsugi 150 Injection 1's
Mankind Pharma Pvt Ltd
₹7218.5
(₹5919.2 per unit)
67% CHEAPERRX
Haltrust 150 Injection 1's
Halsted Pharma Pvt Ltd
₹18000
(₹14760.0 per unit)
19% CHEAPERRX
Herclon 150Mg Inj
Cipla Ltd
₹17851.5
(₹15709.3 per unit)
14% CHEAPERRX
Hertraz 150mg Injection
Mylan Pharmaceuticals Pvt Ltd
₹19500
(₹15990.0 per unit)
12% CHEAPERRX
Herti 150 Injection 1's
Hetero Healthcare Pvt Ltd
₹16298
(₹16298.0 per unit)
10% CHEAPERRX
Trazumab 150 Injection 1's
Emcure Pharmaceuticals Ltd
₹22310.5
(₹18294.61 per unit)
RX
Vicentra 150 mg Powder For Injection 1's
Adley Formulations
₹22800
(₹22800.0 per unit)
24% COSTLIER
Verified Ingredients and Effects
Composition:
TRASTUZUMAB-150MG
Uses:
Breast Cancer, Stomach Cancer.
Medicinal Benefits:
Hervycta Plus 150 Injection contains Trastuzumab, which is used for treating patients with HER2-positive breast cancer and HER2-positive metastatic gastroesophageal adenocarcinoma. This medicine works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in the mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of programmed cell death.
FAQs
Hervycta Plus 150 Injection contains Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.
Inform your doctor whether you have received any other cancer treatment. Hervycta Plus 150 Injection may cause a decrease in left ventricular ejection fraction, cardiomyopathy, hypersensitivity reactions, pulmonary toxicity, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Hervycta Plus 150 Injection.
